GlassScriptPhysician profile
Yinan Wei
NPI 1154703130
$5,108.82
in general payments reported to CMS, 2019-2025
12 companies · $2,983 in 2025
The $2,983 reported for 2025 was more than what 86% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.92 · 2020: $1,366 · 2022: $128 · 2023: $305 · 2024: $291 · 2025: $2,983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,338 · Food and Beverage: $936 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,337.59 |
| Food and Beverage | $936.19 |
| Education | $305.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,543.76 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Enterra Medical, INC. | $1,401.95 | 2025 | |
| Intuitive Surgical, INC. | $1,129.49 | 2020 | |
| Medical Device Business Services, INC. | $305.00 | 2023 | |
| Medtronic, INC. | $210.93 | 2024 | Signia, Sonicision |
| Zimmer Biomet Holdings, INC. | $122.47 | 2020 | |
| Allergan, INC. | $114.38 | 2022 | |
| Novo Nordisk INC | $80.10 | 2024 | |
| Kci USA, INC. | $75.16 | 2020 | |
| Ethicon US, LLC | $49.58 | 2019-2022 | |
| Acell, INC. | $38.96 | 2020 | |
| Smith+Nephew, INC. | $37.04 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yinan Wei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.